chr8-41836250-T-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001142446.2(ANK1):​c.126+60105A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.43 in 152,182 control chromosomes in the GnomAD database, including 14,774 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 14774 hom., cov: 33)

Consequence

ANK1
NM_001142446.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.610

Publications

1 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001142446.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_001142446.2
c.126+60105A>T
intron
N/ANP_001135918.1P16157-21

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000265709.14
TSL:1
c.126+60105A>T
intron
N/AENSP00000265709.8P16157-21
ANK1
ENST00000705521.1
c.126+60105A>T
intron
N/AENSP00000516136.1A0A994J4W8

Frequencies

GnomAD3 genomes
AF:
0.430
AC:
65398
AN:
152064
Hom.:
14745
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.492
Gnomad AMI
AF:
0.259
Gnomad AMR
AF:
0.359
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.786
Gnomad SAS
AF:
0.406
Gnomad FIN
AF:
0.500
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.377
Gnomad OTH
AF:
0.415
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.430
AC:
65480
AN:
152182
Hom.:
14774
Cov.:
33
AF XY:
0.439
AC XY:
32662
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.493
AC:
20444
AN:
41506
American (AMR)
AF:
0.360
AC:
5504
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1335
AN:
3468
East Asian (EAS)
AF:
0.786
AC:
4066
AN:
5174
South Asian (SAS)
AF:
0.404
AC:
1954
AN:
4832
European-Finnish (FIN)
AF:
0.500
AC:
5302
AN:
10600
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.377
AC:
25660
AN:
67992
Other (OTH)
AF:
0.420
AC:
887
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1938
3876
5814
7752
9690
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.411
Hom.:
1635
Bravo
AF:
0.424
Asia WGS
AF:
0.610
AC:
2120
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.51
DANN
Benign
0.53
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs906290; hg19: chr8-41693768; API